YAP1 and diabetic kidney disease: Collectively, our study, integrating results from bioinformatic analysis of transcriptomics data, in vitro investigations, and pathological analyses of biopsy-approved DKD kidney sections, unveils the inactivation of YAP1 at both transcription and post-translation levels under the context of DKD.